Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK)

[1]  C. Borner,et al.  Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c , 1998, Nature.

[2]  R. Herrmann,et al.  MTS1 expression and prognosis in acute myeloid leukemia , 1997, Annals of Hematology.

[3]  F. Cavalli,et al.  Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK). , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  D. Huhn,et al.  Analysis of the p53 and MDM‐2 gene in acute myeloid leukemia , 1996, European journal of haematology.

[5]  W. Wilmanns,et al.  Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. , 1996, Leukemia.

[6]  E. Ruaro,et al.  Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. , 1996, Oncogene.

[7]  E. Liu,et al.  Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase , 1996, Molecular and cellular biology.

[8]  G. Huez,et al.  Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. , 1995, Blood.

[9]  P. Godowski,et al.  Reevaluation of the roles of protein S and gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3 , 1995, Cell.

[10]  R. Herrmann,et al.  Nonradioactive quantification of mdr1 mRNA by polymerase chain reaction amplification coupled with HPLC. , 1995, Clinical chemistry.

[11]  Pamela F. Jones,et al.  The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases , 1995, Cell.

[12]  H. Yamane,et al.  Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6 , 1995, Nature.

[13]  C. Basilico,et al.  The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding , 1995, Molecular and cellular biology.

[14]  R. Koski,et al.  The Transforming Receptor Tyrosine Kinase, Axl, Is Post-translationally Regulated by Proteolytic Cleavage (*) , 1995, The Journal of Biological Chemistry.

[15]  D. Huhn,et al.  Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. , 1994, Blood.

[16]  J. Rowley,et al.  Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. , 1993, Blood.

[17]  G. Wang,et al.  Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. , 1993, Oncogene.

[18]  A. Schulz,et al.  The murine ufo receptor: molecular cloning, chromosomal localization and in situ expression analysis. , 1992, Oncogene.

[19]  A. Schulz,et al.  A novel putative tyrosine kinase receptor with oncogenic potential. , 1991, Oncogene.

[20]  R. Espinosa,et al.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase , 1991, Molecular and cellular biology.

[21]  P. Lansdorp,et al.  Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. , 1991, Blood.

[22]  Ian Diamond,et al.  Analysis of Binary Data. 2nd Edn. , 1990 .

[23]  B. Hjelle,et al.  Transforming genes in chronic myelogenous leukemia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[25]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[26]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[27]  Bernice W. Polemis.  Nonparametric Statistics for the Behavioral Sciences , 1959 .

[28]  D.,et al.  Regression Models and Life-Tables , 2022 .